Biochemical pharmacology
Corrigendum to "Almonertinib inhibits liver cancer progression by triggering autophagy-dependent ferroptosis through inhibition of the PI3K/Akt1/mTOR pathway". [Biochem. Pharmacol. 245 (2026) 117628].
Lulu Liang, Xueshuang Wang, Baier Sun, Yipeng Sun, Jing Chen, Jiebang Jiang, Li Meng, Sisi He, Rongpeng Li, Fei Wang
Published: 202610.1016/j.bcp.2026.117690
No abstract available for this study.